Hims & Hers Health (HIMS) Debt Ratio (2019 - 2025)

Hims & Hers Health (HIMS) posted Debt Ratio of 0.0 for Q4 2025, down 89.77% sequentially from 0.02 in Q1 2024.

Hims & Hers Health (HIMS) Debt Ratio (2019 - 2025) Analysis & Trends

Hims & Hers Health has reported Debt Ratio for 7 years, with the latest figure at 0.0 in Q4 2025.

Quarterly Debt Ratio changed N/A year-over-year to 0.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 0.0 (changed N/A YoY) and the FY2025 annual result came in at 0.0, changed N/A from the prior year.
Debt Ratio retreated to 0.0 in Q4 2025 per HIMS's latest filing, from 0.02 in the prior quarter.
Over five years, Debt Ratio peaked at 0.1 in Q4 2021 and troughed at 0.0 in Q4 2025.
A 5-year average of 0.03 and a median of 0.03 in 2022 frame the typical range for Debt Ratio.
The sharpest annual moves came in 2021 and 2023: Debt Ratio soared 2714.15% in 2021, then plunged 64.12% in 2023.
Over 5 years, Debt Ratio stood at 0.1 in 2021, then slumped by 66.73% to 0.03 in 2022, then sank by 50.42% to 0.02 in 2023, then decreased by 1.54% to 0.02 in 2024, then slumped by 89.77% to 0.0 in 2025.
According to Business Quant data, Debt Ratio over the past three periods registered 0.0, 0.02, and 0.02 for Q4 2025, Q1 2024, and Q4 2023 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Debt Ratio (Qtr)
1	Haleon	44.38 Bn	43.42 Bn	-	-0.13
2	Teva Pharmaceutical Industries	43.73 Bn	40.08 Bn	2.15 Bn	0.42
3	Zoetis	32.43 Bn	30.76 Bn	1.05 Bn	0.60
4	Takeda Pharmaceutical	28.61 Bn	22.81 Bn	5.10 Bn	0.32
5	United Therapeutics	22.11 Bn	19.45 Bn	683.80 Mn	-
6	Viatris	18.94 Bn	18.05 Bn	1.46 Bn	0.38
7	Neurocrine Biosciences	15.54 Bn	15.15 Bn	935.80 Mn	-
8	Elanco Animal Health	12.01 Bn	11.48 Bn	798.00 Mn	0.29
9	Dr Reddys Laboratories	10.15 Bn	9.98 Bn	-	0.12
10	Hims & Hers Health	7.97 Bn	7.13 Bn	480.80 Mn	-

Download Data